Harrisson S et al. Six month interim results of MSDC-0602K in a large phase 2b NASH study demonstrate significant improvement in liver enzymes and glycemic control (NCT02784444). (Abstract PS-111)
Langetermijneffectiviteit van Ad26.RSV.preF-RSV preF-eiwitvaccin
dec 2024 | Vaccinatie, Virale infecties